Explore Products
Primary Cells

Human Chronic Myeloid Leukemia Peripheral Blood Mononuclear Cells (Accelerated/Blast Crisis)

  • BSL

    1

  • 267
Chronic Myeloid Leukemia (Chronic Myeloid Leukemia) is often divided into three phases, based on clinical characteristics and laboratory findings. In the absence of interventions, Chronic Myeloid Leukemia typically begins in the chronic phase (85% of Chronic Myeloid Leukemia patients). Over the course of several years, the cancer progresses to an accelerated phase and ultimately to […]
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Species

Human

Cat.No

ABC-TC3362

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Primary Cells
Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Chronic Myeloid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Description

Human Chronic Myeloid Leukemia Peripheral Blood Mononuclear Cells (Accelerated/Blast Crisis) are mononuclear cell populations isolated from the peripheral blood of patients with chronic myeloid leukemia (CML) in the accelerated phase or blast phase. Morphologically, cells in the accelerated phase show abnormal differentiation of granulocytes and mononuclear cells, and imbalance of nuclear cytoplasm ratio.CML-AP/BC cells typically exhibit the Philadelphia chromosome (t(9;22)(q34;q11)), along with secondary chromosomal abnormalities like trisomy 8 or i(17q), detected via karyotyping or FISH. In the blast phase, blasts are the main cells, with reduced cytoplasmic granules, loose nuclear chromatin, and prominent nucleoli.These cells highly express CD34, CD117, and BCR-ABL1 fusion transcripts, detected by flow cytometry and RT-PCR. Its functional abnormality is manifested by the continuous activation of tyrosine kinase driven by the BCR-ABL1 fusion gene, which regulates the cell cycle through signaling pathways such as Ras and PI3K, inhibits apoptosis and promotes proliferation.

View Product Image

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • Human Chronic Myeloid Leukemia Peripheral Blood Mononuclear Cells (Accelerated/Blast Crisis) can serve as an ideal model for studying BCR-ABL1 oncogenic signaling. By analyzing its abnormally activated Ras/MAPK, PI3K/AKT and other pathways, the molecular mechanism of the transformation of CML from the chronic phase to the progressive phase is revealed.

Inquiring Human Chronic Myeloid Leukemia Peripheral Blood Mononuclear Cells (Accelerated/Blast Crisis)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button